Translocation of NF-κB and Expression of Cyclooxygenase-2 Are Enhanced by Ketamine-Induced Ulcerative Cystitis in Rat Bladder

Yung Shun Juan, Yi Lun Lee, Cheng Yu Long, Jhen Hong Wong, Mei Yu Jang, Jian He Lu, Wen Jeng Wu, Yen Shun Huang, Wei Chiao Chang, Shu Mien Chuang

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

The number of ketamine abusers has increased significantly recently. Ketamine abusers exhibit urinary frequency, urgency, and at times urinary incontinence. Our aim was to investigate the role of transcription factor NF-κB and cyclooxygenase (COX)-2 in ketamine-induced cystitis. Sprague-Dawley rats were distributed into three groups, which received saline or treatment with ketamine or ketamine combined with a Cox-2 inhibitor (parecoxib). In addition, the toxic effect of ketamine and its metabolites were examined by primary urothelial cell culture. The ketamine-treated group displayed bladder hyperactivity and decreased bladder capacity. Treatment with ketamine + COX-2 inhibitor prevented these bladder dysfunctions. These bladder dysfunctions were accompanied by increases in the expression of NF-κB and COX-2 at the protein and mRNA levels. Ketamine treatment also enhanced bladder interstitial fibrosis, whereas ketamine + Cox-2 inhibitor decreased the intensity of fibrosis. Treatment of primary urothelial cells in vitro with ketamine or urine obtained from ketamine-treated rats stimulated the expression of NF-κB p65 and COX-2. Ketamine also initiated NF-κB translocation from cell cytoplasm to nucleus. Treatment with NF-κB inhibitor suppressed Cox-2 mRNA expression. Promoter-deletion analysis revealed that NF-κB was a necessary transcription factor for COX-2 gene (Ptgs2) activation. These results demonstrate that the regulation of COX-2 via the NF-κB pathway is involved in the inflammatory signaling of ketamine-induced cystitis in rat urinary bladder.

Original languageEnglish
Pages (from-to)2269-2285
Number of pages17
JournalAmerican Journal of Pathology
Volume185
Issue number8
DOIs
Publication statusPublished - Aug 1 2015

Fingerprint

Cystitis
Ketamine
Cyclooxygenase 2
Urinary Bladder
Fibrosis
Transcription Factors
Messenger RNA
Primary Cell Culture
Cyclooxygenase 2 Inhibitors
Poisons
Urinary Incontinence
Transcriptional Activation
Sprague Dawley Rats

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Translocation of NF-κB and Expression of Cyclooxygenase-2 Are Enhanced by Ketamine-Induced Ulcerative Cystitis in Rat Bladder. / Juan, Yung Shun; Lee, Yi Lun; Long, Cheng Yu; Wong, Jhen Hong; Jang, Mei Yu; Lu, Jian He; Wu, Wen Jeng; Huang, Yen Shun; Chang, Wei Chiao; Chuang, Shu Mien.

In: American Journal of Pathology, Vol. 185, No. 8, 01.08.2015, p. 2269-2285.

Research output: Contribution to journalArticle

Juan, Yung Shun ; Lee, Yi Lun ; Long, Cheng Yu ; Wong, Jhen Hong ; Jang, Mei Yu ; Lu, Jian He ; Wu, Wen Jeng ; Huang, Yen Shun ; Chang, Wei Chiao ; Chuang, Shu Mien. / Translocation of NF-κB and Expression of Cyclooxygenase-2 Are Enhanced by Ketamine-Induced Ulcerative Cystitis in Rat Bladder. In: American Journal of Pathology. 2015 ; Vol. 185, No. 8. pp. 2269-2285.
@article{f0e81e50d5624ed9bd74bd343131ea01,
title = "Translocation of NF-κB and Expression of Cyclooxygenase-2 Are Enhanced by Ketamine-Induced Ulcerative Cystitis in Rat Bladder",
abstract = "The number of ketamine abusers has increased significantly recently. Ketamine abusers exhibit urinary frequency, urgency, and at times urinary incontinence. Our aim was to investigate the role of transcription factor NF-κB and cyclooxygenase (COX)-2 in ketamine-induced cystitis. Sprague-Dawley rats were distributed into three groups, which received saline or treatment with ketamine or ketamine combined with a Cox-2 inhibitor (parecoxib). In addition, the toxic effect of ketamine and its metabolites were examined by primary urothelial cell culture. The ketamine-treated group displayed bladder hyperactivity and decreased bladder capacity. Treatment with ketamine + COX-2 inhibitor prevented these bladder dysfunctions. These bladder dysfunctions were accompanied by increases in the expression of NF-κB and COX-2 at the protein and mRNA levels. Ketamine treatment also enhanced bladder interstitial fibrosis, whereas ketamine + Cox-2 inhibitor decreased the intensity of fibrosis. Treatment of primary urothelial cells in vitro with ketamine or urine obtained from ketamine-treated rats stimulated the expression of NF-κB p65 and COX-2. Ketamine also initiated NF-κB translocation from cell cytoplasm to nucleus. Treatment with NF-κB inhibitor suppressed Cox-2 mRNA expression. Promoter-deletion analysis revealed that NF-κB was a necessary transcription factor for COX-2 gene (Ptgs2) activation. These results demonstrate that the regulation of COX-2 via the NF-κB pathway is involved in the inflammatory signaling of ketamine-induced cystitis in rat urinary bladder.",
author = "Juan, {Yung Shun} and Lee, {Yi Lun} and Long, {Cheng Yu} and Wong, {Jhen Hong} and Jang, {Mei Yu} and Lu, {Jian He} and Wu, {Wen Jeng} and Huang, {Yen Shun} and Chang, {Wei Chiao} and Chuang, {Shu Mien}",
year = "2015",
month = "8",
day = "1",
doi = "10.1016/j.ajpath.2015.04.020",
language = "English",
volume = "185",
pages = "2269--2285",
journal = "American Journal of Pathology",
issn = "0002-9440",
publisher = "Elsevier Inc.",
number = "8",

}

TY - JOUR

T1 - Translocation of NF-κB and Expression of Cyclooxygenase-2 Are Enhanced by Ketamine-Induced Ulcerative Cystitis in Rat Bladder

AU - Juan, Yung Shun

AU - Lee, Yi Lun

AU - Long, Cheng Yu

AU - Wong, Jhen Hong

AU - Jang, Mei Yu

AU - Lu, Jian He

AU - Wu, Wen Jeng

AU - Huang, Yen Shun

AU - Chang, Wei Chiao

AU - Chuang, Shu Mien

PY - 2015/8/1

Y1 - 2015/8/1

N2 - The number of ketamine abusers has increased significantly recently. Ketamine abusers exhibit urinary frequency, urgency, and at times urinary incontinence. Our aim was to investigate the role of transcription factor NF-κB and cyclooxygenase (COX)-2 in ketamine-induced cystitis. Sprague-Dawley rats were distributed into three groups, which received saline or treatment with ketamine or ketamine combined with a Cox-2 inhibitor (parecoxib). In addition, the toxic effect of ketamine and its metabolites were examined by primary urothelial cell culture. The ketamine-treated group displayed bladder hyperactivity and decreased bladder capacity. Treatment with ketamine + COX-2 inhibitor prevented these bladder dysfunctions. These bladder dysfunctions were accompanied by increases in the expression of NF-κB and COX-2 at the protein and mRNA levels. Ketamine treatment also enhanced bladder interstitial fibrosis, whereas ketamine + Cox-2 inhibitor decreased the intensity of fibrosis. Treatment of primary urothelial cells in vitro with ketamine or urine obtained from ketamine-treated rats stimulated the expression of NF-κB p65 and COX-2. Ketamine also initiated NF-κB translocation from cell cytoplasm to nucleus. Treatment with NF-κB inhibitor suppressed Cox-2 mRNA expression. Promoter-deletion analysis revealed that NF-κB was a necessary transcription factor for COX-2 gene (Ptgs2) activation. These results demonstrate that the regulation of COX-2 via the NF-κB pathway is involved in the inflammatory signaling of ketamine-induced cystitis in rat urinary bladder.

AB - The number of ketamine abusers has increased significantly recently. Ketamine abusers exhibit urinary frequency, urgency, and at times urinary incontinence. Our aim was to investigate the role of transcription factor NF-κB and cyclooxygenase (COX)-2 in ketamine-induced cystitis. Sprague-Dawley rats were distributed into three groups, which received saline or treatment with ketamine or ketamine combined with a Cox-2 inhibitor (parecoxib). In addition, the toxic effect of ketamine and its metabolites were examined by primary urothelial cell culture. The ketamine-treated group displayed bladder hyperactivity and decreased bladder capacity. Treatment with ketamine + COX-2 inhibitor prevented these bladder dysfunctions. These bladder dysfunctions were accompanied by increases in the expression of NF-κB and COX-2 at the protein and mRNA levels. Ketamine treatment also enhanced bladder interstitial fibrosis, whereas ketamine + Cox-2 inhibitor decreased the intensity of fibrosis. Treatment of primary urothelial cells in vitro with ketamine or urine obtained from ketamine-treated rats stimulated the expression of NF-κB p65 and COX-2. Ketamine also initiated NF-κB translocation from cell cytoplasm to nucleus. Treatment with NF-κB inhibitor suppressed Cox-2 mRNA expression. Promoter-deletion analysis revealed that NF-κB was a necessary transcription factor for COX-2 gene (Ptgs2) activation. These results demonstrate that the regulation of COX-2 via the NF-κB pathway is involved in the inflammatory signaling of ketamine-induced cystitis in rat urinary bladder.

UR - http://www.scopus.com/inward/record.url?scp=84937836611&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84937836611&partnerID=8YFLogxK

U2 - 10.1016/j.ajpath.2015.04.020

DO - 10.1016/j.ajpath.2015.04.020

M3 - Article

C2 - 26073037

AN - SCOPUS:84937836611

VL - 185

SP - 2269

EP - 2285

JO - American Journal of Pathology

JF - American Journal of Pathology

SN - 0002-9440

IS - 8

ER -